New combo therapy aims to shrink head and neck tumors before surgery
NCT ID NCT07371234
First seen Feb 01, 2026 · Last updated May 16, 2026 · Updated 22 times
Summary
This study tests a new approach for people with advanced head and neck cancer that can be surgically removed. Before surgery, patients receive low-dose radiation combined with an immunotherapy drug to shrink the tumor and improve long-term outcomes. The goal is to see if this combination can reduce the chance of cancer coming back. About 22 participants will be enrolled.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LOCALLY ADVANCED HEAD AND NECK SQUAMOUS CELL CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The Fifth Affiliated Hospital,Sun Yat-sen University
RECRUITINGGuangdong, China
Conditions
Explore the condition pages connected to this study.